Maternal Anxiety Related to How the Pediatrician Provided Prenatal Information About Preterm Birth
NCT ID: NCT03646578
Last Updated: 2018-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
65 participants
OBSERVATIONAL
2014-11-01
2017-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study assessed whether or not specific written information about prematurity delivered at admission to the unit combined with an oral explanation from a pediatrician would decrease women's anxiety compared to an oral explanation alone. This was a prospective, single-center observational study.Women were included in the high-risk pregnancies department and distributed into two groups: receiving ''only oral'' information for a prenatal clinical consultation with a senior pediatrician or receiving ''combined'' oral information + a booklet about prematurity given to the women at admission. The primary endpoint was the change in anxiety-state (before and after the information procedure) evaluated by the State Trait Anxiety Inventory-Y (STAI-Y).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emotional Reactions of Mothers Facing Premature Births
NCT03345641
Neurodevelopmental Outcome After Prenatal Anesthesia
NCT06052878
Organizing the Information Given to Parents of NICU Infants in Order to Reduce Their Anxiety
NCT00699127
Description of Practices Implemented in the Birth of Living Children Before 24 Weeks of Amenorrhea
NCT03403894
Assessing the Impact of Mount Sinai Parenting Center's Newborn Class
NCT04121390
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study assessed whether or not specific written information about prematurity delivered at admission to the unit combined with an oral explanation from a pediatrician would decrease women's anxiety compared to an oral explanation alone. Material and methods.This was a prospective, single-center observational study.Women were included in the high-risk pregnancies department and distributed into two groups: receiving ''only oral'' information for a prenatal clinical consultation with a senior pediatrician or receiving ''combined'' oral information
\+ a booklet about prematurity given to the women at admission.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
State of anxiety
Patient anxiety assessment by STAI-Y-A self-assessment questionnaire provided before and after pediatric interview.
The assessment is given to patients upon arrival in the hospitalization service of pregnancies and again after the pediatric interview. This pediatric interview should take place between 1 and 7 days after admission to the hospital ward.The second part includes a 6-week inclusion period with assessment of patients' state of anxiety by a STAI-Y-A self-assessment questionnaire given before and after pediatric interview associated with the delivery of a written document. on prematurity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Term \<34 SA
Exclusion Criteria
* no understanding of the questionnaire
* foetus presenting a pathology or malformation that is life-threatening
* patient presenting a risk of delivery before passing the pediatrician or presenting a risk of imminent delivery
* patient hospitalized without risk of premature delivery.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Tourneux, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU AMIENS
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2017_843_0038
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.